Ephedrine versus ondansetron in the prevention of hypotension during cesarean delivery: a randomized, double-blind, placebo-controlled trial

被引:11
|
作者
Nivatpumin, P. [1 ]
Thamvittayakul, V. [1 ]
机构
[1] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anesthesiol, Bangkok, Thailand
关键词
Cesarean delivery; Anesthesia; Spinal; Hypotension; Ephedrine; Ondansetron; PROPHYLACTIC INTRAVENOUS EPHEDRINE; BEZOLD-JARISCH REFLEX; SPINAL-ANESTHESIA; MATERNAL HYPOTENSION; ANESTHETIZED RATS; SECTION; METAANALYSIS; PHENYLEPHRINE;
D O I
10.1016/j.ijoa.2016.02.003
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Maternal hypotension is common after spinal anesthesia for cesarean delivery. We compared the effects of prophylactic ephedrine with ondansetron on post-spinal blood pressure. Methods: One hundred and sixty-eight term, singleton parturients were enrolled in this prospective, double-blind, placebo controlled trial. Patients were randomized to receive either prophylactic intravenous ephedrine 10 mg (Group E), ondansetron 8 mg (Group 0) or normal saline (Group P) immediately after spinal anesthesia. The primary outcome was maternal blood pressure between spinal block and delivery; secondary outcomes were nausea and vomiting scores, Apgar scores, numbers requiring intraoperative vasoconstrictors and the dose of vasoconstrictors required. Results: Fifty-six patients were recruited to each group, but two in Group P were excluded from the analysis owing to protocol violations. There were no significant differences between the groups in maternal systolic, diastolic or mean arterial pressures, or the proportion of patients experiencing hypotension. The proportion of patients in Group E requiring intraoperative ephedrine or any vasoconstrictor (ephedrine and/or norepinephrine) was significantly lower than that in Group P (P=0.023 and 0.034, respectively). The proportion of patients in Group 0 requiring intraoperative norepinephrine was significantly lower than that in Group P (P=0.02). There was no difference in the proportions of patients in Groups E and 0 requiring any vasoconstrictors (P=0.34). Conclusions: There was no significant difference in maternal blood pressure in women administered prophylactic ephedrine or ondansetron after spinal anesthesia for cesarean delivery compared with placebo. Ephedrine reduced the proportion of patients requiring a rescue vasoconstrictor before delivery. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 50 条
  • [1] A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch
    Murphy, M
    Reaich, D
    Pai, P
    Finn, P
    Carmichael, AJ
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (02) : 314 - 317
  • [2] Use of propofol for prevention of post-delivery nausea during cesarean section: a double-blind, randomized, placebo-controlled trial
    Kun Niu
    Hui Liu
    Ruo-Wen Chen
    Qi-Wu Fang
    Hui Wen
    Su-Mei Guo
    John P. Williams
    Jian-Xiong An
    Journal of Anesthesia, 2018, 32 : 748 - 755
  • [3] Use of propofol for prevention of post-delivery nausea during cesarean section: a double-blind, randomized, placebo-controlled trial
    Niu, Kun
    Liu, Hui
    Chen, Ruo-Wen
    Fang, Qi-Wu
    Wen, Hui
    Guo, Su-Mei
    Williams, John P.
    An, Jian-Xiong
    JOURNAL OF ANESTHESIA, 2018, 32 (05) : 748 - 755
  • [4] Prevention of postoperative hypotension following spinal anesthesia for TURP : a double-blind randomized controlled trial comparing ephedrine with placebo
    Verdeyen, J.
    Ory, J. P.
    Wyckmans, W.
    Vandermeersch, E.
    Jamaer, L.
    Van Assche, A.
    ACTA ANAESTHESIOLOGICA BELGICA, 2008, 59 (02) : 73 - 78
  • [5] RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTION
    MURPHY, JJ
    HEPTINSTALL, S
    MITCHELL, JRA
    LANCET, 1988, 2 (8604): : 189 - 192
  • [6] Estrogen in the prevention of atherosclerosis - A randomized, double-blind, placebo-controlled trial
    Hodis, HN
    Mack, WJ
    Lobo, RA
    Shoupe, D
    Sevanian, A
    Mahrer, PR
    Selzer, RH
    Liu, CR
    Liu, CH
    Azen, SP
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (11) : 939 - 953
  • [7] Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study
    Taslimi, Shervin
    Vahidi, Hamed
    Pourvaziri, Ali
    Modabbernia, Amirhossein
    Fallah, Arezoo Yeke
    Yazdani, Nasrin
    Taslimi, Negin
    Hosseini, Mostafa
    Zarandi, Masoud Motesadi
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2013, 270 (05) : 1635 - 1641
  • [8] Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study
    Shervin Taslimi
    Hamed Vahidi
    Ali Pourvaziri
    Amirhossein Modabbernia
    Arezoo Yeke Fallah
    Nasrin Yazdani
    Negin Taslimi
    Mostafa Hosseini
    Masoud Motesadi Zarandi
    European Archives of Oto-Rhino-Laryngology, 2013, 270 : 1635 - 1641
  • [9] Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled crossover trial
    Mwesigwa, Naome
    Vernetti, Patricio Millar
    Kirabo, Annet
    Black, Bonnie
    Ding, Tan
    Martinez, Jose
    Palma, Jose-Alberto
    Biaggioni, Italo
    Kaufmann, Horacio
    Shibao, Cyndya A.
    CLINICAL AUTONOMIC RESEARCH, 2024, 34 (06) : 561 - 569
  • [10] Celecoxib Versus Placebo in Tonsillectomy: A Prospective, Randomized, Double-Blind Placebo-Controlled Trial
    Van Daele, Douglas J.
    Bodeker, Kellie L.
    Trask, Douglas K.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2016, 125 (10): : 785 - 800